Wizcure Pharmaa Class II Recall for Eye Drops Due to Sterility Issues

The FDA has issued a Class II recall for Wizcure Pharmaa's Vista Gel Hypromellose USP 0.3% eye drops, identified by recall number D-0347-2026. The recall is due to a lack of assurance of sterility, stemming from the product not being manufactured in conformance with current good manufacturing practices (cGMP). This recall affects a specific lot of eye drops distributed nationwide in the USA.

This action signifies a critical failure in manufacturing quality control, requiring immediate attention from any entities involved in the distribution or handling of this product. While specific compliance deadlines are not detailed, the nature of a sterility issue necessitates prompt removal from shelves and potential customer notification. Companies should review their own cGMP compliance and recall procedures, especially if handling similar ophthalmic products. Non-compliance with recall directives can lead to further FDA enforcement actions.